Integrating Behavioral Therapy w/ Pharmacotherapy in Treating Patients w/ Substance Use Disorders скачать в хорошем качестве

Integrating Behavioral Therapy w/ Pharmacotherapy in Treating Patients w/ Substance Use Disorders

Talk Title: Integrating Behavioral Therapy with Pharmacotherapy in Treating Patients with Substance Use Disorders Roger D. Weiss, M.D. of McLean Hospital and Harvard Medical School, will speak about the role of behavioral therapy in the context of pharmacotherapy for substance use disorders. He will talk about the goals of behavioral therapy when combined with medication (including medication adherence). Dr. Weiss will review studies of combined pharmacotherapy and behavioral therapy with different medications and different behavioral interventions. Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders. Dr. Weiss was named a member of honor by the Spanish Society for Dual Disorders in 2011, and has received numerous other awards, including the H. David Archibald Award for Outstanding Research and/or Practice in the Addictions from The Centre for Addiction and Mental Health in Toronto (2007), the Jack H. Mendelson Research Award from McLean Hospital (2012), and the Dan Anderson Research Award from the Hazelden Foundation (2012). Learn more.